Stuart A Arbuckle Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Stuart A Arbuckle is EVP, COO of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 62,935 shares of VRTX, which is worth approximately $30.8 Million. The most recent transaction as insider was on Feb 17, 2021, when has been sold 6,240 shares (Common Stock) at a price of $211.75 per share, resulting in proceeds of $1,321,320. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.9K

26.65% 3M change

26.65% 12M change

Total Value Held $30.8 Million

Stuart A Arbuckle Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2021	SELL Payment of exercise price or tax liability	$1,321,320 $211.75 p/Share	6,240 Reduced 10.11%	55,460 Common Stock
Feb 11 2021	SELL Open market or private sale	$1,089,102 $211.23 p/Share	5,156 Reduced 7.71%	61,700 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$664,110 $214.16 p/Share	3,101 Reduced 4.43%	66,856 Common Stock
Feb 03 2021	SELL Open market or private sale	$332,944 $214.25 p/Share	1,554 Reduced 2.17%	69,957 Common Stock
Feb 03 2021	BUY Exercise of conversion of derivative security	$134,452 $86.52 p/Share	1,554 Added 2.13%	71,511 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	34,778 Added 33.21%	69,957 Common Stock
Nov 16 2020	SELL Open market or private sale	$1,563 $223.29 p/Share	7 Reduced 0.02%	35,179 Common Stock
Nov 03 2020	SELL Open market or private sale	$329,469 $212.15 p/Share	1,553 Reduced 4.23%	35,179 Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	$134,366 $86.52 p/Share	1,553 Added 4.06%	36,732 Common Stock

Also insider at

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

Director

IMGN

ImmunoGen, Inc. Healthcare

Director

SAA